The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other ...

Enzymes, the core catalysts in life, drive critical biological processes ranging from metabolic regulation to energy ...

Monoclonal antibodies lead biosimilar approvals because of their large market size, well-defined regulatory pathways, and ...

In 2021, the 30.7 million beneficiaries accounted for over $2 billion in payments for the 101 generic drugs. Under the ...

SEOUL: Celltrion, a major South Korean biopharmaceutical firm, said on Monday that its biosimilar for asthma and other chronic allergic diseases has obtained approval for sales in the US market. The ...

FLuID enables privacy-preserving knowledge sharing in drug discovery using knowledge distillation. The results show that the approach expands applicability domains and fosters collaboration across ...

Mr MacGill pleaded not guilty to one count of taking part in the supply of a large commercial quantity of a prohibited drug, with the court told that he claimed he simply introduced the two men ...

a major step in its investigation into thousands of alleged extrajudicial killings in a bloody "war on drugs" that defined his presidency.

The denosumab biosimilar market is poised for disruption with 3 FDA-approved biosimilars, at least 5 awaiting approval, and launches anticipated to start in May 2025, while ongoing patent litigation ...

Specialty drugs now account for 51% of total prescription spending, and this figure is expected to rise by 8% through 2025. Meanwhile, biosimilars present a potential $54 billion in savings over ...

A panelist discusses how managing biosimilars requires close collaboration between payers and health systems to optimize patient care and cost savings, while sharing insights about program ...

The Biosimilars Council recently commented on a report released by Matrix Global Advisors, titled U.S. Biosimilars Market: Addressing Barriers to Success in the Second Decade, which recommends ...